Giuliana Rancic and bioTheranostics Inch Towards a Cure with Mediaplanet’s “Breast Cancer Care” Campaign

Share Article

About one in eight American women (just over 12 percent) will develop invasive breast cancer over the course of her lifetime. With such staggering statistics, it remains vital to detect the disease in its early stages, which has shown to be best way to survive.

Giuliana Rancic graces the cover of Mediaplanet's Breast Cancer Care campaign

Mediaplanet today announces distribution of its first cross-platform edition of “Breast Cancer Care,” a campaign that seeks to not only raise awareness but allow our readers to create a plan of action to see their doctors and take the proper screening, diagnostic, testing precautions and treatments to prevent or make living with breast cancer more manageable.

The print component of “Breast Cancer Care” is distributed within this weekend’s edition of USA Today in New York, Los Angeles, Chicago, Washington DC/Baltimore, Seattle, Minnesota with a circulation of approximately 450,000 copies and an estimated readership of 1.3 million. The digital component is distributed nationally through a vast social media strategy and across a network of top news sites and partner outlets. To explore the digital version of the campaign, click here.

Giuliana Rancic, TV personality and advocate, graces the cover of the print publication. Through an exclusive interview on the interior, the star opens up about life after her breast cancer. “Throughout my battle with breast cancer, I learned how strong I really am,” she shares. “I learned how truly powerful a positive attitude can be and I also learned that it’s okay to go through all of the emotions that come with being diagnosed with cancer”.

This edition of “Breast Cancer Care” was made possible with the support of bioTheranostics, a leader in helping physicians improve the care and management of cancer patients, offering a suite of proprietary molecular diagnostic tests that allow treatment to be tailored to individual patients. The company’s Breast Cancer IndexSM helps oncologists make difficult decisions about extended endocrine therapy for estrogen receptor-positive breast cancer patients based on its unique ability to predict risk of late disease recurrence and identify which patients are likely to benefit from continuing therapy beyond five years. To read more, be sure to pick up a copy of USA Today in one of the distributed markets.

About Mediaplanet

Mediaplanet is the leading independent publisher of content-marketing campaigns covering a variety of topics and industries. We turn consumer interest into action by providing readers with motivational editorial, pairing it with relevant advertisers, and distributing it within top newspapers and online platforms around the world.

Press Contact:
Jessica Guggenheimer
Jessica.Guggenheimer(at)mediaplanet(dot)com
646-922-1401

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Jessica Guggenheimer
Mediaplanet
+1 646-922-1400
Email >
@MediaplanetCA
Follow >
Visit website